1. Home
  2. TDOC vs COLL Comparison

TDOC vs COLL Comparison

Compare TDOC & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Teladoc Health Inc.

TDOC

Teladoc Health Inc.

HOLD

Current Price

$9.63

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$23.71

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TDOC
COLL
Founded
2002
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Nursing Services
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2015
2015

Fundamental Metrics

Financial Performance
Metric
TDOC
COLL
Price
$9.63
$23.71
Analyst Decision
Hold
Buy
Analyst Count
23
8
Target Price
$8.58
★ $49.00
AVG Volume (30 Days)
★ 4.7M
574.5K
Earning Date
10-28-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 80.58
N/A
EPS
N/A
★ N/A
Revenue
★ $2,406,840,000.00
$780,567,000.00
Revenue This Year
N/A
$6.73
Revenue Next Year
N/A
$1.37
P/E Ratio
N/A
★ N/A
Revenue Growth
18.41
★ 23.62
52 Week Low
$4.40
$21.43
52 Week High
$9.89
$50.79

Technical Indicators

Market Signals
Indicator
TDOC
COLL
Relative Strength Index (RSI) 78.98 55.97
Support Level $6.18 $21.67
Resistance Level $9.89 $23.87
Average True Range (ATR) 0.42 0.76
MACD 0.33 0.19
Stochastic Oscillator 90.39 67.22

Price Performance

Historical Comparison
TDOC
COLL

About TDOC Teladoc Health Inc.

Teladoc Health Inc is engaged in the provision of virtual healthcare services, connecting patients, providers, and healthcare systems through technology-enabled platforms. The company has two reportable segments: Integrated Care and BetterHelp. The Integrated Care segment provides virtual healthcare solutions, including primary care, mental health, chronic care management, and telehealth enablement services for employers, insurers, and healthcare systems, mainly on a business-to-business basis, while the BetterHelp segment offers direct-to-consumer online mental health services, including counseling and therapy delivered through digital platforms. It generates the majority of its revenue from the Integrated Care segment.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: